Skip to content
ppharmaranks
Menu
Class IIOngoing

Lucky Super Soft recall

FDA recall D-0630-2026 · initiated Jun 2, 2026

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Jun 24, 2026How we research

Dabur India Limited recalled Lucky Super Soft in Jun 2026 — an FDA Class II recall (D-0630-2026) because CGMP Deviations; deficiencies observed during FDA inspection.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

CGMP Deviations; deficiencies observed during FDA inspection

The manufacturing process itself

The FDA found the process itself out of compliance, usually before any defective product was identified.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot# 0002, Lot# 0003, within expiry

Quantity recalled: 2503 tubes

Details

Product
Lucky Super Soft, First Aid Triple Antibiotic Ointment, Bacitracin zinc 400 units, neomycin sulphate 3.5 mg, polymyxin B sulphate 5000 units, Net Wt. 0.5 oz (14g) tubes, Manufactured for Delta Brands Inc., 580 White Plains Rd., Tarrytown, NY 10591 USA, Made in India, UPC 8 08829 10372 4.
Recalling company
Dabur India Limited
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
US Nationwide.
Initiated
Jun 2, 2026
FDA report date
Jun 24, 2026
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Lucky Super Soft recalled?
Dabur India Limited recalled Lucky Super Soft in Jun 2026 — an FDA Class II recall (D-0630-2026) because CGMP Deviations; deficiencies observed during FDA inspection. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Lucky Super Soft recalled?
Per the FDA enforcement record, the reason for recall D-0630-2026 was: CGMP Deviations; deficiencies observed during FDA inspection
Is a recalled Lucky Super Soft dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Lucky Super Soft are affected?
Distributed: US Nationwide.. The recall covers these lots — Lot# 0002, Lot# 0003, within expiry. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0630-2026.

Source: openFDA Drug Enforcement record D-0630-2026

← All drug recalls